Viewing Study NCT05175235

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2026-01-16 @ 7:17 PM
Study NCT ID: NCT05175235
Status: UNKNOWN
Last Update Posted: 2023-03-03
First Post: 2021-12-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements
Sponsor: National University Hospital, Singapore
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None personalized oncology View
None personalized dose selection View
None immunotherapy View
None dose optimisation View
None Cancer View
None Artificial Intelligence View
None CURATE.AI View
None Nivolumab View
None Sequential ctDNA View
None Chemotherapy View